ABIOMED News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.07.14	Abiomed Buys Germany-based ECP (RTTNews)
08.04.14	Abiomed Gets CE Marking Approval In EU To Market Impella RP Device (RTTNews)
20.03.14	Abiomed Closes Patient Enrollment In Recover Right Impella Study - Quick Facts (RTTNews)
10.10.13	Upcoming Earnings Schedules, Acquisitions, Partnerships, and Unrestricted Grants for Community Programs - Research Report on Intuitive Surgical, Abbott, MAKO Surgical, Allscripts, and ABIOMED (PR Newswire)
07.08.13	Financial Results Releases, Succession Plans, and New Appointments to Board of Directors - Research Report on ResMed, Sirona, Align, ABIOMED, and Globus (PR Newswire)
25.01.10	Impella 2.5 Patient Procedure at Mount Sinai Medical Center Featuring New Product Enhancements: Webcast Available (Businesswire)
11.03.09	Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5 (Businesswire)
30.01.09	Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification (Businesswire)
10.11.08	Abiomed Announces Record Revenue of $20 Million, Representing 75% Growth for Second Quarter of Fiscal 2009 (Businesswire)
08.10.08	Abiomed to Showcase Impella(R) 2.5 Heart Recovery Device at TCT 2008 (Businesswire)
12.09.08	Abiomed Announces Preliminary Schedule of Events at TCT 2008 (Businesswire)
22.05.08	Abiomed Appoints Martin P. Sutter to Its Board of Directors (Businesswire)
21.05.08	Abiomed Announces 26% Growth and Record Revenue of $17.5 Million for Fourth Quarter of Fiscal 2008 (Businesswire)
24.01.08	Abiomed to Host Symposium on Spectrum of Heart Recovery Technologies at STS 2008 (Businesswire)
25.10.07	Abiomed Announces Results of Impella(R) 2.5 FDA PROTECT I Safety Trial for High-Risk PCI Cases (Businesswire)
18.07.07	Abiomed Announces Canadian Regulatory Approvals of Impella Circulatory Support Technologies (Businesswire)
28.03.07	Abiomed Announces Data on Impella 2.5 for Improved Cardiac Function for Pre-Shock Acute Myocardial Infarction (Businesswire)
13.03.07	Abiomed ernennt General Manager für europäischen Geschäftsbereich (Businesswire)
13.03.07	Abiomed Appoints General Manager for European Operations (Businesswire)
02.03.07	Abiomed to Showcase Impella 2.5 Advanced Circulatory Support Technologies at American College of Cardiology's Annual Scientific Sessions (Businesswire)
06.02.07	Abiomed veröffentlicht Geschäftszahlen für das dritte Quartal des Bilanzjahres 2007 mit einem Umsatzwachstum von 23% Wirtschafts- und Technikredaktion (Businesswire)
24.01.07	Abiomed Announces Development of Pediatric Circulatory Support Technology (Businesswire)
04.12.06	Abiomed Announces Webcast on Clinical Best Practices for Heart Recovery (Businesswire)
25.08.06	Abiomed gibt Termine für seine Präsentationen über Unterstützungstechnologie für die Herzerholung bei der Konferenz der International Society of Rotary Blood Pumps bekannt (Businesswire)
24.08.06	Abiomed Announces Heart Recovery Technology Presentations at International Society of Rotary Blood Pumps Meeting (Businesswire)
28.06.06	FDA genehmigt Abiomeds IDE minimal invasive Herzunterstützungssysteme IMPELLA 5.0; fortschrittliche Medizintechnologie zum Einsatz bei geringer Herzleistung nach Herz-OP (Businesswire)
21.06.06	Abiomed Appoints Dr. Daniel Raess as Company Medical Advisor; Experienced Cardiovascular Surgeon Strengthens Clinical Expertise Offerings to Customers (Businesswire)
22.05.06	ABIOMED Announces French Regulatory Approval of the AB5000 Circulatory Support System; ABIOMED to Open French Office for Direct Sales and Clinical Support for Customers (Businesswire)
17.05.06	ABIOMED Launches Expanded Customer Services for U.S. Hospitals; Customer Reimbursement Webcast Scheduled, Aligning Recovery Outcomes and Economics (Businesswire)
16.05.06	ABIOMED Announces Schedule of Events for Breakthrough IMPELLA Technology at EuroPCR Conference in Paris (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Lonza Grp	548.20	4.94 %	K V
CieFinRichemont	135.60	1.46 %	K V
UBS Group	28.62	1.13 %	K V
Holcim	90.18	1.08 %	K V
Alcon	76.56	0.63 %	K V
Swiss Re	127.80	-0.31 %	K V
Sika	230.60	-0.60 %	K V
Swiss Life Hldg	687.20	-0.66 %	K V
Part Grp Hldg	1’284.50	-0.96 %	K V
Kuehne+Nagel Int	205.00	-2.80 %	K V

Nachrichten zu ABIOMED Inc.

Aktien Top/Flop

Meistgelesene Nachrichten